Blue cone monochromatism

Blue cone monochromatism (BCM), also known as S-cone monochromatism or X-linked achromatopsia, is a rare inherited retinal disorder affecting color vision and visual acuity. In this condition, both the red (long-wavelength, L) and green (medium-wavelength, M) cone photoreceptors in the retina are absent or nonfunctional, leaving only the blue (short-wavelength, S) cones and rod photoreceptors to mediate vision. The disorder is caused by mutations in or rearrangements of the OPN1LW and OPN1MW gene cluster on the X chromosome, which encode the red and green cone opsins, or by mutations in the locus control region (LCR) that regulates expression of these genes. Affected individuals, almost exclusively males, typically present in infancy or early childhood with markedly reduced visual acuity (usually in the range of 20/60 to 20/200), severely impaired color discrimination, nystagmus (involuntary rhythmic eye movements), and photophobia (light sensitivity). Because only S-cones and rods function, patients have very limited color perception and may be unable to distinguish most hues, though they retain some blue-yellow discrimination. The condition primarily affects the visual system, specifically the cone photoreceptor cells of the retina. Visual acuity tends to remain relatively stable over time, though mild progressive changes have been reported in some patients. Currently, there is no cure or definitive treatment for blue cone monochromatism. Management is supportive and includes the use of tinted or filtered lenses to reduce photophobia, low-vision aids, and educational accommodations. Gene therapy approaches are under investigation as potential future treatments, given the well-characterized genetic basis of the disorder. Electroretinography (ERG) and genetic testing are important tools for confirming the diagnosis and distinguishing BCM from other forms of achromatopsia and cone dysfunction syndromes.

Common questions about Blue cone monochromatism